When stimulated with IL-2, however, CART cells of patients showed a higher expansion rate compared to CART cells of HDs [on final culture day 20 (IL-2): 26-fold expansion (CLL patients) vs. 9-fold expansion (HDs)]. Here, IL2 is linked to B-cell chronic lymphocytic leukemia.